OBs Drive Cord Blood Adoption

The bottleneck here is not consumer demand, it is point of care education inside prenatal care. Cord blood banking is a decision that has to be made before delivery, so if an OB does not raise it early, the family usually misses the window. That makes OBs the key distribution layer, much like prenatal genetic testing companies that win by fitting into routine OB workflows rather than relying on parents to discover the option on their own.

• Anja is selling a time sensitive pregnancy workflow, not just a lab service. Parents enroll before birth, bring a kit to the hospital, collect cord blood, cord tissue, and placenta at delivery, then pay $35, $65, or $85 per month depending on how much they store. If the clinician never mentions it, that workflow never starts.
  1 sacra 2 sacra
• Mainstream OB guidance has stayed cautious. ACOG says patients should hear the pros and cons of public versus private banking, but also says routine private banking is not supported by current evidence and recommends public banking as the standard route. That helps explain why many OBs treat the category as niche rather than as a standard counseling topic.
  3 acog
• The closest analog is BillionToOne, which grew by making prenatal screening easy for OB practices to offer during normal visits, then billing insurance. Anja is earlier and mostly cash pay, but the same rule applies, the company that best packages education, logistics, and office workflow can shape what expecting parents even hear about in pregnancy.
  5 sacra 6 sacra

Going forward, the winners in cord blood banking will look less like old storage vendors and more like pregnancy workflow companies. As more cord blood therapies reach formal approval and more states push physician education around cord blood, the market should shift from optional upsell to a more standard prenatal discussion, which would expand the funnel for companies that already own the kit, pickup, and education layer.